Stiolto Respimat (olodaterol/tiotropium FDC) - Boehringer Ingelheim
Airway Response to Dual Bronchodilation and Its Association with Inflammatory Markers in Treatment-Naïve Chronic Obstructive Pulmonary Disease: A Quantitative Computed Tomography Study. (PubMed, Life (Basel)) - Sep 27, 2026 - "Lung function and chest CT were assessed at baseline and after 12 weeks of tiotropium/olodaterol (n = 34)... Initial dual bronchodilator therapy improved lung function and CT-derived airway measurements. In this cohort, no statistically significant association was detected between blood eosinophil count and airway response, whereas higher hs-CRP was associated with a smaller Ai/BSA increase." 
Journal • Chronic Obstructive Pulmonary Disease • Immunology • Pulmonary Disease • Respiratory Diseases • CRP
http://www.ncbi.nlm.nih.gov/pubmed/42795312
 
Deimante Hoppenot; Ieva Dimiene; Jurgita Zaveckiene; Kestutis Malakauskas; Kristina Bieksiene; Marius Zemaitis; Neringa Vaguliene; Skaidrius Miliauskas
 
Sep 27, 2026
 
Prev Next